Position in JNJ
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$310,269,402
-$165,059,772 QoQ
Shares Held
1,269,307
-44.7% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026KBC Group NV holds $2,118,683,406 across 10 Drug Manufacturers - General names. JNJ ranks #3 (14.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
576,203 | $529,974,231 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
2,679,656 | $373,463,655 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,269,307 | $310,269,402 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
4,009,205 | $243,158,282 | |
| 5 | PFE |
Pfizer Inc
|
8,471,914 | $237,891,345 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,217,611 | $146,466,425 | |
| 7 | ABBV |
AbbVie Inc.
|
669,647 | $145,641,525 | |
| 8 | AMGN |
Amgen Inc
|
252,179 | $88,729,180 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $310,269,402 | 1,269,307 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $475,329,174 | 2,296,831 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $349,722,700 | 1,886,111 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $148,862,817 | 974,552 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $65,680,931 | 396,050 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $131,300,787 | 907,902 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $149,864,012 | 924,744 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $187,330,786 | 1,281,683 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $146,352,167 | 925,167 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $281,387,954 | 1,795,253 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $309,347,379 | 1,986,179 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $324,172,078 | 1,958,507 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $231,616,500 | 1,494,300 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $293,142,019 | 1,659,451 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $191,703,449 | 1,173,503 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $212,116,639 | 1,194,956 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $227,588,309 | 1,284,141 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $260,978,575 | 1,525,566 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $213,323,250 | 1,320,887 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $172,072,247 | 1,044,508 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $167,101,712 | 1,016,743 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $171,946,778 | 1,092,558 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $122,796,521 | 824,802 | Shares | Defined | 2022-02-14 | |
| 2020-06-30 | $137,881,667 | 980,457 | Shares | Defined | 2022-02-14 | |
| 2020-03-31 | $90,170,756 | 687,644 | Shares | Defined | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||